News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
104last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
The Wall Street Journal117d agoneutral
In the Weight-Loss Wars, Novo’s Obesity Pill Is Pulling Way Ahead of Lilly’sReuters122d agoneutral
India's Dr Reddy's on track for worst day in 3 years as semaglutide supplies hitInvestor's Business Daily124d agoneutral
Eli Lilly's Market Cap Balloons Again On This IPO's SetbackInvestor's Business Daily124d agobullish
Why This Novo Nordisk Rival Just Soared Near A Profit-Taking ZoneThe Wall Street Journal129d agoneutral
Why Medicare Isn’t a Game Changer for Weight-Loss DrugmakersInvestor's Business Daily135d agoneutral
Nike Stock Languishes, But Looming Earnings Report Fuels Turnaround OptimismGuruFocus.com142d agobullish
Novo Nordisk Stock Rally as Owner Unveils $69 Million Obesity Research PushReuters142d agoneutral
Stocks turn lower as US-Iran talks hit early snag; oil erase early lossesPharmaceutical Technology149d agobullish
Novo Nordisk comeback stirs as Wegovy pill wins UK approvalThe Wall Street Journal150d agoneutral
Novo Nordisk’s Wegovy Weight Loss Pill Approved in the U.K.